ZJAWISKO FOTONADWRAŻLIWOŚCI – ISTOTNE DZIAŁANIE NIEPOŻĄDANE POWSZECHNIE STOSOWANYCH LEKÓW

Angelika Lis; Katarzyna Wyszomierska; Katarzyna Znajdek; Łukasz Szeleszczuk; Monika Zielińska-Pisklak

doi:10.56782/pps.8

Published : 2021-06-09

Vol. 19 No. 3 (2021)

PHOTOSENSITIVITY PHENOMENON – A SIGNIFICANT ADVERSE EFFECT OF COMMONLY USED DRUGS

Angelika Lis

Katarzyna Wyszomierska

Katarzyna Znajdek

Łukasz Szeleszczuk

Monika Zielińska-Pisklak

DOI: https://doi.org/10.56782/pps.8

Abstract

Drug-induced photosensitivity is an adverse effect of topically or systemically administered therapeutic substances caused by exposure to UVA, UVB, and visible light. It accounts for 8% of skin reactions to medications. It may occur as an effect of phototoxicity, when photoactivation of a drug or its metabolite in the skin results in the formation of a photoproduct or reactive oxygen species (ROS) or be a consequence of photoallergy – delayed type IV hypersensitivity reaction to the photoproduct. The occurrence of these phenomena depends on the structure of the molecule and physical and chemical properties of a xenobiotic. Many drugs have the potential to cause photosensitivity, including antimicrobial medications (doxycycline, tetracycline, isoniazid), antifungal drugs (voriconazole), non-steroidal anti-inflammatory drugs (naproxen, ketoprofen, piroxicam), medicines used in cardiovascular diseases (amiodarone, hydrochlorothiazide), antipsychotics (chlorpromazine, thioridazine), furanocoumarins (psoralen derivatives) as well as plant substances such as St. John's wort. Diagnosis of photosensitivity is based on a phototest. Prevention of phototoxicity and photoallergy includes avoiding sun exposure and the use of sunscreens, while treatment focuses on symptoms’ alleviation and administration of anti-inflammatory drugs in the case of photoallergy.

Keywords:

drug-induced photosensitivity, phototoxicity, photoallergy

Similar Articles

Bartłomiej Kot, Mateusz Moczulski, Agnieszka Czajkowska, Arkadiusz Kocur, Pharmacotherapy of apnea in the premature neonatological subpopulation – therapeutic opportunities, pharmacokinetic implications and recommendations for therapeutic drug monitoring , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Aleksandra Mikulska, Arkadiusz Kocur, Pharmacotherapy with high doses of methotrexate (HDMTX) in oncology – how should chemotherapy be conducted based on therapeutic drug monitoring? , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Paulina Oleksa, Daria Żuraw, Kacper Jasiński, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Karolina Haczkur-Pawłowska, Drugs and other chemical substances inducing diabetes – review of the literature , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Kinga Kocur, Katarzyna Camlet, Anna Ziobro, Mateusz Ziomek, Wojciech Kaźmierski, Paulina Lis, Jakub Jurek, Anna Lis, Renaissance of Ketamine , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Agnieszka Kalicka, Natalia Tarłowska, Counterfeit and illegal medicinal products as an example of drugs that do not meet the basic quality requirements , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Paulina Brewczyńska, Justyna Makowska, Dorota Skrajnowska, Marta Teryks, Andrzej Tokarz, ADDICTION TO CONVENTIONAL AND ELECTRONIC CIGARETTES AND THE RISKS OF PHARMACOTHERAPY IN SMOKERS. , Prospects in Pharmaceutical Sciences: Vol. 13 No. 3 (2015)
Magdalena Bamburowicz-Klimkowska, Mirosław M. Szutowski, STRATEGIES TO COMBAT MULTIDRUG RESISTANCE OF CANCER , Prospects in Pharmaceutical Sciences: Vol. 10 No. 1 (2012)
Izabela Łuczak-Zielkiewicz, Mirosław M. Szutowski, DIAGNOSTIC VALUE OF HAIR ANALYSIS , Prospects in Pharmaceutical Sciences: Vol. 11 No. 8 (2013)
Łukasz Dobrek, Analysis of the activity of the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in the field of clinical trials, registration of medicinal products and monitoring of adverse drug reactions in 2017-2021 , Prospects in Pharmaceutical Sciences: Vol. 20 No. 4 (2022)
Karolina Gimpel, Piotr Luliński, Dorota Maciejewska, SELECTED SYSTEMS OPTIMIZING DRUG DELIVERY , Prospects in Pharmaceutical Sciences: Vol. 7 No. 3 (2009)

1 2 3 4 5 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Lis, A., Wyszomierska, K., Znajdek, K., Szeleszczuk, Łukasz, & Zielińska-Pisklak, M. (2021). PHOTOSENSITIVITY PHENOMENON – A SIGNIFICANT ADVERSE EFFECT OF COMMONLY USED DRUGS. Prospects in Pharmaceutical Sciences, 19(3), 18–27. https://doi.org/10.56782/pps.8

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

International Organization for Standardization, Definitions of Solar Irradiance Spectral Categories (Standard nr 21348), 2007, Internet: https://www.iso.org/standard/39911.html (dostęp 23.04.2021).

Chantorn, R., Lim, H. W., Shwayder, T. A., Photosensitivity disorders in children: part I, Journal of the American Academy of Dermatology, 2012, 67(6): 1093: 1-18. DOI: https://doi.org/10.1016/j.jaad.2012.07.033

Ray, R. S., Haldar, C., Dwivedi, A., Agarwal, N., Singh, J., Photocarcinogenesis & Photoprotection, Springer, Singapore, 2018, 77-84. DOI: https://doi.org/10.1007/978-981-10-5493-8

Elkeeb, D., Elkeeb, L., Maibach, H., Photosensitivity: a current biological overview, Cutaneous and Ocular Toxicology, 2012, 31(4): 263-272. DOI: https://doi.org/10.3109/15569527.2012.656293

Moore, D. E., Drug-induced cutaneous photosensitivity, Drug Safety, 2002, 25(5): 345-372. DOI: https://doi.org/10.2165/00002018-200225050-00004

Lugović-Mihić, L., Duvančić, T., Ferček, I., Vuković, P., Japundžić, I., Ćesić, D., Drug-induced photosensitivity-a continuing diagnostic challenge, Acta Clinica Croatica, 2017, 56(2): 277-283. DOI: https://doi.org/10.20471/acc.2017.56.02.11

Goetze, S., Hiernickel, C., Elsner, P., Phototoxicity of doxycycline: A systematic review on clinical manifestations, frequency, cofactors, and prevention, Skin Pharmacology and Physiology, 2017, 30: 76–80. DOI: https://doi.org/10.1159/000458761

Monteiro, A.F., Rato, M., Martins, C., Drug-induced photosensitivity: Photoallergic and phototoxic reactions, Clinical Dermatology, 2016, 34: 571–581. DOI: https://doi.org/10.1016/j.clindermatol.2016.05.006

Schmidt, F., Wenzel, J., Halland, N., Güssregen, S., Delafoy, L., Czich, A., Computational investigation of drug phototoxicity: photosafety assessment, photo-toxophore identification, and machine learning, Chemical Research in Toxicology, 2019, 32(11): 2338-2352. DOI: https://doi.org/10.1021/acs.chemrestox.9b00338

Bogumiła Zuba, E., Koronowska, S., Osmola-Mańkowska, A., Jenerowicz, D., Drug-induced photosensitivity, Acta Dermatovenerologica Croatica, 2016, 24(1): 55-64.

Katsambas, A. D., Lotti, T. M., Dessinioti, C., D'Erme, A. M., European handbook of dermatological treatments, Springer, Berlin, Germany, 2015, 233-252. DOI: https://doi.org/10.1007/978-3-662-45139-7

R. Mang, H. Stege, J. Krutmann, Mechanisms of phototoxic and photoallergic reactions, w: Johansen J.D., Frosch J.P., Lepoittevin J.P, Contact Dermatitis, Springer, Berlin, Heidelberg, 2011, 155–163. DOI: https://doi.org/10.1007/978-3-642-03827-3_8

Khandpur S., Porter R.M., Boulton S.J., Anstey A., Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science, British Journal of Dermatology, 2017, 176: 902–909. DOI: https://doi.org/10.1111/bjd.14935

Kim, W. B., Shelley, A. J., Novice, K., Joo, J., Lim, H. W., Glassman, S. J., Drug-induced phototoxicity: a systematic review, Journal of the American Academy of Dermatology, 2018, 79(6): 1069-1075. DOI: https://doi.org/10.1016/j.jaad.2018.06.061

Petković, H., Lukežič, T., Šušković, J. Biosynthesis of oxytetracycline by Streptomyces rimosus: past, present and future directions in the development of tetracycline antibiotics, Food technology and biotechnology, 2017, 55(1): 3-13. DOI: https://doi.org/10.17113/ftb.55.01.17.4617

Hall, J. C., Hall, B. J., Cutaneous drug eruptions: diagnosis, histopathology and therapy, Springer, London, 2015, 107-121. DOI: https://doi.org/10.1007/978-1-4471-6729-7

Blakely, K. M., Drucker, A. M., Rosen, C. F., Drug-induced photosensitivity – an update: Culprit drugs, prevention and management, Drug Safety, 2019, 42(7): 827-847. DOI: https://doi.org/10.1007/s40264-019-00806-5

Elmas, Ö. F., Akdeniz, N., A case of doxycyclin-induced photoonycholysis with dermoscopic features, Balkan Medical Journal, 2020, 37(2): 113. DOI: https://doi.org/10.4274/balkanmedj.galenos.2019.2019.11.22

McCarthy, S., Bourke, J. F. Image gallery: minocycline-induced photo-onycholysis with pigmentation, British Journal of Dermatology, 2019, 180(4): 102. DOI: https://doi.org/10.1111/bjd.17417

Wlodek, C., Narayan, S., A reminder about photo-onycholysis induced by tetracycline, and the first report of a case induced by lymecycline, Clinical and Experimental Dermatology, 2014, 6(39): 746-747. DOI: https://doi.org/10.1111/ced.12350

Drucker, A. M., Rosen, C. F., Drug-induced photosensitivity, Drug Safety, 2011, 34(10): 821-837. DOI: https://doi.org/10.2165/11592780-000000000-00000

Domagala, J. M., Structure-activity and structure-side-effect relationships for the quinolone antibacterials, Journal of Antimicrobial Chemotherapy, 1994, 33(4): 685-706. DOI: https://doi.org/10.1093/jac/33.4.685

Angelika Lis

biuletynfarmacji@wum.edu.pl

Affiliation:

Studenckie Koło Naukowe „Free Radicals” przy Zakładzie Chemii Fizycznej, Wydział Farmaceutyczny, Warszawski Uniwersytet Medyczny, Banacha 1, 02-097 Warszawa Poland

Katarzyna Wyszomierska

biuletynfarmacji@wum.edu.pl

Affiliation:

Studenckie Koło Naukowe „Free Radicals” przy Zakładzie Chemii Fizycznej, Wydział Farmaceutyczny, Warszawski Uniwersytet Medyczny, Banacha 1, 02-097 Warszawa Poland

Katarzyna Znajdek

znajdek.katarzyna@gmail.com

Affiliation:

Studenckie Koło Naukowe „Free Radicals” przy Zakładzie Chemii Fizycznej, Wydział Farmaceutyczny, Warszawski Uniwersytet Medyczny, Banacha 1, 02-097 Warszawa Poland

Łukasz Szeleszczuk

biuletynfarmacji@wum.edu.pl

Affiliation:

Zakład Chemii Fizycznej, Wydział Farmaceutyczny, Warszawski Uniwersytet Medyczny, Banacha 1, 02-097 Warszawa Poland

Monika Zielińska-Pisklak

biuletynfarmacji@wum.edu.pl

Affiliation:

Zakład Chemii Biomateriałów, Katedra Chemii Analitycznej i Biomateriałów, Wydział Farmaceutyczny,Warszawski Uniwersytet Medyczny, Banacha 1, 02-097 Warszawa Poland

PHOTOSENSITIVITY PHENOMENON – A SIGNIFICANT ADVERSE EFFECT OF COMMONLY USED DRUGS

Angelika Lis

Katarzyna Wyszomierska

Katarzyna Znajdek

Łukasz Szeleszczuk

Monika Zielińska-Pisklak

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Angelika Lis

Katarzyna Wyszomierska

Katarzyna Znajdek

Łukasz Szeleszczuk

Monika Zielińska-Pisklak